Combination Paclitaxel, Carboplatin, and Gemcitabine Is an Active Treatment for Advanced Urothelial Cancer PURPOSE: The prognostic significance of the rate of decline of the serum tumor marker ...
March 27, 2008 — Within the Surveillance, Epidemiology, and End Results (SEER) registry, there is substantial variation in tumor-marker reporting for testis cancer, according to an analysis published ...
Serum tumor markers play a vital role in the excellent outcomes now expected for men with testicular cancer. The relative survival for all cases of testicular cancer is approximately 96% at 5 years. 1 ...